These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1113389)

  • 21. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
    Sommer HH; Fosså SD; Lien HH
    Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of renal cell carcinoma. 2. Combined chemotherapy using ACNU and VBL].
    Kobayashi M; Imai K; Nakai K; Kumasaka F; Suzuki T; Ito Y; Yamanaka H; Sugihara S
    Hinyokika Kiyo; 1986 Mar; 32(3):375-83. PubMed ID: 3460318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study.
    Tranum BL; Haut A; Rivkin S; Weber E; Quagliana JM; Shaw M; Tucker WG; Smith FE; Samson M; Gottlieb J
    Cancer; 1975 Apr; 35(4):1148-53. PubMed ID: 1116106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of brain tumors with 1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Takeuchi J; Nakao S; Handa H
    Nihon Geka Hokan; 1973 Apr; 42(2):184-9. PubMed ID: 4738478
    [No Abstract]   [Full Text] [Related]  

  • 27. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
    Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
    Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
    Lindell TD; Moseley HS; Fletcher WS
    Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of malignant melanoma with methyl CCNU.
    Young RC; Canellos GP; Chabner BA; Schein PS; Brereton HD; DeVita VT
    Clin Pharmacol Ther; 1974 Jun; 15(6):617-22. PubMed ID: 4601745
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.
    Johnson FD; Jacobs EM
    Cancer; 1971 Jun; 27(6):1306-12. PubMed ID: 4253429
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 39. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 40. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.